Claritev Posts Strong Q2 2026 Results, Raises Full-Year Guidance
Event summary
- Revenue grew 6.6% YoY to $257.5M in Q2 2026.
- Bookings exceeded $70M for the first half of 2026, targeting $100M for the full year.
- Adjusted EBITDA increased by 1.1% YoY to $155.8M.
- Free cash flow rose to $54.6M from $36.6M in Q2 2025.
The big picture
Claritev’s Q2 2026 results reflect a year of strategic transformation, with expanded solutions and vertical markets driving growth. The company’s heightened focus on AI as both an operational and innovation lever underscores its commitment to long-term sustainability. With five consecutive quarters of YoY revenue growth, Claritev is positioning itself for continued expansion in the healthcare technology sector.
What we're watching
- Execution Risk
- Whether Claritev can sustain its transformation momentum and meet its $100M bookings target for the year.
- Market Expansion
- The pace at which Claritev can diversify its business through new markets and verticals, particularly in the TPA sector.
- Financial Health
- How the company's focus on client success will impact long-term profitability amid ongoing net losses.
Related topics